Vinpocetine

CAS 42971-09-5 2 current records 1 historicalSmall Molecule

Who holds supplier records for Vinpocetine? 2 organisations hold a current record for Vinpocetine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Hungary (1) and Switzerland (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Vinpocetine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/vinpocetine

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Vinpocetine. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • HungaryCEP Company GMP cert on record
  • LINNEA S.A.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SwitzerlandCEP
Need Vinpocetine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Vinpocetine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
LINNEA S.A. LavertezzoCH
R1-CEP 2016-251 - Rev 00
Vinpocetine
Oct 2022—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2011-059 - Rev 01
Vinpocetine
May 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Vinpocetine are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • MEDIMPEX NORTH AMERICA INC
    Inactive DMF 3854 · filed Jun 1980

Overview

Vinpocetine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL71752).

Chemical identity

IUPAC name
ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
Canonical SMILES
CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC
InChIKey
DDNCQMVWWZOMLN-IRLDBZIGSA-N
Synonyms
Apovincaminic acid ethyl ester, AY-27,255, AY-27255, Bravinton, Cavinton, Ceractin, Ethyl apovincamin-22-oate, NSC-760093, Rgh 4405, Tcv 3b, Ultra-vinca, Vinpocetina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Vinpocetine?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Vinpocetine: Gedeon Richter (Hungary) and LINNEA S.A. (Switzerland). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Vinpocetine records mean?

1 organisation has only inactive Type II DMFs for Vinpocetine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Vinpocetine have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Vinpocetine on the EDQM register, including LINNEA S.A. Lavertezzo (CH) and GEDEON RICHTER PLC. Budapest (HU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Vinpocetine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Vinpocetine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.